Clinical Trial Update: A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioavailability study of rifabutin and lopinavir/ritonavir in healthy adult subjects sponsored by Abbott; the trial involving HIV and tuberculosis condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Tuberculosis

Drugs mentioned

• Lopinavir/ritonavir (lopinavir/ritonavir)
• RIFABUTIN (Rifabutin)

Snippet

Sponsor: Abbott | Conditions: HIV, Tuberculosis | Phase 1 | Status: TERMINATED